Tilray, Inc. - Class 2 (TLRY): Price and Financial Metrics

Tilray, Inc. - Class 2 (TLRY)

Today's Latest Price: $5.71 USD

0.26 (-4.36%)

Updated Oct 30 4:00pm

Add TLRY to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 240 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

TLRY Stock Summary

  • TLRY's went public 2.28 years ago, making it older than merely 5.33% of listed US stocks we're tracking.
  • In terms of twelve month growth in earnings before interest and taxes, Tilray Inc is reporting a growth rate of 389.41%; that's higher than 96.15% of US stocks.
  • Revenue growth over the past 12 months for Tilray Inc comes in at 112.18%, a number that bests 95.23% of the US stocks we're tracking.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Tilray Inc are METC, YGYI, NEPT, EVTC, and EGOV.
  • TLRY's SEC filings can be seen here. And to visit Tilray Inc's official web site, go to www.tilray.com.

TLRY Stock Price Chart Interactive Chart >

Price chart for TLRY

TLRY Price/Volume Stats

Current price $5.71 52-week high $24.10
Prev. close $5.97 52-week low $2.43
Day low $5.43 Volume 7,135,000
Day high $5.95 Avg. volume 8,531,802
50-day MA $5.75 Dividend yield N/A
200-day MA $8.69 Market Cap 726.19M

Tilray, Inc. - Class 2 (TLRY) Company Bio

Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. was founded in 2018 and is based in Nanaimo, Canada.

TLRY Latest News Stream

Event/Time News Detail
Loading, please wait...

TLRY Latest Social Stream

Loading social stream, please wait...

View Full TLRY Social Stream

Latest TLRY News From Around the Web

Below are the latest news stories about Tilray Inc that investors may wish to consider to help them evaluate TLRY as an investment opportunity.

Lower incidence of vomiting and nausea with Tilray GMP-produced products

Australian researchers have published preliminary results findings of first clinical trial of Tilray's (TLRY) GMP-produced products, that it shows a significant improvement in the control of chemotherapy-induced nausea and vomiting. A quarter of the patients taking medicinal cannabis experienced no vomiting and nausea, compared to 14 percent of people who...

Seeking Alpha | September 28, 2020

Global CBD Oil Extract Market 2020-2026 Refreshing Trends || Major Giants – Canopy Growth Corporation, Aphria Inc., Aurora Cannabis., MARICANN INC, Tilray, GW Pharmaceuticals plc

According to this CBD Oil Extract Market report, the key market players are making moves like product launches, joint ventures, developments, mergers and acquisitions which has influence on the market and Industry as a whole and also affecting the sales,

OpenPR | September 28, 2020

Tilray Medical Cannabis Product Shows Promise Reducing Nausea and Vomiting Caused by Chemotherapy in World First Clinical Trial

NANAIMO, B.C.--(BUSINESS WIRE)---- $TLRY #TLRY--Tilray announced preliminary results from a world-first clinical trial finding for chemotherapy induced nausea and vomiting.

Business Wire | September 28, 2020

Cannabis Stock Gainers And Losers From September 22, 2020

GAINERS: CordovaCann (OTCQB: LVRLF ) shares closed up 29.03% at $0.20 Flower One Hldgs (OTCQX: FLOOF ) shares closed up 16.65% at $0.14 Aurora Cannabis (NYSE: ACB ) shares closed up 15.64% at $7.32 Cresco Labs (OTCQX: CRLBF ) shares closed up 8.8% at $5.98 Tilray (NASDAQ: TLRY ) shares closed up 7.3% at $5.37 Nextleaf Solutions (OTCQB: OILFF ) shares closed up 7% at $0.16 Cannabics Pharmaceuticals (OTCQB: CNBX ) shares closed up 6.45% at $0.18 MGC Pharmaceuticals (PINK: MGCLF ) shares closed up 6.25% at $0.02 Marrone Bio Innovations (NASDAQ: Full story available on Benzinga.com

Benzinga | September 22, 2020

Top Analyst Upgrades and Downgrades: ADP, Carrier, Darden, KLA, Lam Research, Oracle, Snowflake, Southern, Tilray, UPS, Visa and More

No summary available.

24/7 Wall street | September 21, 2020

Read More 'TLRY' Stories Here

TLRY Price Returns

1-mo 17.73%
3-mo -22.63%
6-mo -21.13%
1-year -74.41%
3-year N/A
5-year N/A
YTD -66.67%
2019 -75.72%
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Continue Researching TLRY

Want to see what other sources are saying about Tilray Inc's financials and stock price? Try the links below:

Tilray Inc (TLRY) Stock Price | Nasdaq
Tilray Inc (TLRY) Stock Quote, History and News - Yahoo Finance
Tilray Inc (TLRY) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.7712 seconds.